Cargando…
The cytokine receptor CRLF3 is a human neuroprotective EV-3 (Epo) receptor
The evolutionary conserved orphan cytokine receptor-like factor 3 (CRLF3) has been implicated in human disease, vertebrate hematopoiesis and insect neuroprotection. While its specific functions are elusive, experimental evidence points toward a general role in cell homeostasis. Erythropoietin (Epo)...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165946/ https://www.ncbi.nlm.nih.gov/pubmed/37168680 http://dx.doi.org/10.3389/fnmol.2023.1154509 |
_version_ | 1785038345207808000 |
---|---|
author | Knorr, Debbra Y. Rodriguez Polo, Ignacio Pies, Hanna S. Schwedhelm-Domeyer, Nicola Pauls, Stephanie Behr, Rüdiger Heinrich, Ralf |
author_facet | Knorr, Debbra Y. Rodriguez Polo, Ignacio Pies, Hanna S. Schwedhelm-Domeyer, Nicola Pauls, Stephanie Behr, Rüdiger Heinrich, Ralf |
author_sort | Knorr, Debbra Y. |
collection | PubMed |
description | The evolutionary conserved orphan cytokine receptor-like factor 3 (CRLF3) has been implicated in human disease, vertebrate hematopoiesis and insect neuroprotection. While its specific functions are elusive, experimental evidence points toward a general role in cell homeostasis. Erythropoietin (Epo) is a major regulator of vertebrate hematopoiesis and a general cytoprotective cytokine. Erythropoietic functions mediated by classical Epo receptor are understood in great detail whereas Epo-mediated cytoprotective mechanisms are more complex due to involvement of additional Epo receptors and a non-erythropoietic splice variant with selectivity for certain receptors. In the present study, we show that the human CRLF3 mediates neuroprotection upon activation with the natural Epo splice variant EV-3. We generated CRLF3 knock-out iPSC lines and differentiated them toward the neuronal lineage. While apoptotic death of rotenone-challenged wild type iPSC-derived neurons was prevented by EV-3, EV-3-mediated neuroprotection was absent in CRLF3 knock-out neurons. Rotenone-induced apoptosis and EV-3-mediated neuroprotection were associated with differential expression of pro-and anti-apoptotic genes. Our data characterize human CRLF3 as a receptor involved in Epo-mediated neuroprotection and identify CRLF3 as the first known receptor for EV-3. |
format | Online Article Text |
id | pubmed-10165946 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101659462023-05-09 The cytokine receptor CRLF3 is a human neuroprotective EV-3 (Epo) receptor Knorr, Debbra Y. Rodriguez Polo, Ignacio Pies, Hanna S. Schwedhelm-Domeyer, Nicola Pauls, Stephanie Behr, Rüdiger Heinrich, Ralf Front Mol Neurosci Molecular Neuroscience The evolutionary conserved orphan cytokine receptor-like factor 3 (CRLF3) has been implicated in human disease, vertebrate hematopoiesis and insect neuroprotection. While its specific functions are elusive, experimental evidence points toward a general role in cell homeostasis. Erythropoietin (Epo) is a major regulator of vertebrate hematopoiesis and a general cytoprotective cytokine. Erythropoietic functions mediated by classical Epo receptor are understood in great detail whereas Epo-mediated cytoprotective mechanisms are more complex due to involvement of additional Epo receptors and a non-erythropoietic splice variant with selectivity for certain receptors. In the present study, we show that the human CRLF3 mediates neuroprotection upon activation with the natural Epo splice variant EV-3. We generated CRLF3 knock-out iPSC lines and differentiated them toward the neuronal lineage. While apoptotic death of rotenone-challenged wild type iPSC-derived neurons was prevented by EV-3, EV-3-mediated neuroprotection was absent in CRLF3 knock-out neurons. Rotenone-induced apoptosis and EV-3-mediated neuroprotection were associated with differential expression of pro-and anti-apoptotic genes. Our data characterize human CRLF3 as a receptor involved in Epo-mediated neuroprotection and identify CRLF3 as the first known receptor for EV-3. Frontiers Media S.A. 2023-04-06 /pmc/articles/PMC10165946/ /pubmed/37168680 http://dx.doi.org/10.3389/fnmol.2023.1154509 Text en Copyright © 2023 Knorr, Rodriguez Polo, Pies, Schwedhelm-Domeyer, Pauls, Behr and Heinrich. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Molecular Neuroscience Knorr, Debbra Y. Rodriguez Polo, Ignacio Pies, Hanna S. Schwedhelm-Domeyer, Nicola Pauls, Stephanie Behr, Rüdiger Heinrich, Ralf The cytokine receptor CRLF3 is a human neuroprotective EV-3 (Epo) receptor |
title | The cytokine receptor CRLF3 is a human neuroprotective EV-3 (Epo) receptor |
title_full | The cytokine receptor CRLF3 is a human neuroprotective EV-3 (Epo) receptor |
title_fullStr | The cytokine receptor CRLF3 is a human neuroprotective EV-3 (Epo) receptor |
title_full_unstemmed | The cytokine receptor CRLF3 is a human neuroprotective EV-3 (Epo) receptor |
title_short | The cytokine receptor CRLF3 is a human neuroprotective EV-3 (Epo) receptor |
title_sort | cytokine receptor crlf3 is a human neuroprotective ev-3 (epo) receptor |
topic | Molecular Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165946/ https://www.ncbi.nlm.nih.gov/pubmed/37168680 http://dx.doi.org/10.3389/fnmol.2023.1154509 |
work_keys_str_mv | AT knorrdebbray thecytokinereceptorcrlf3isahumanneuroprotectiveev3eporeceptor AT rodriguezpoloignacio thecytokinereceptorcrlf3isahumanneuroprotectiveev3eporeceptor AT pieshannas thecytokinereceptorcrlf3isahumanneuroprotectiveev3eporeceptor AT schwedhelmdomeyernicola thecytokinereceptorcrlf3isahumanneuroprotectiveev3eporeceptor AT paulsstephanie thecytokinereceptorcrlf3isahumanneuroprotectiveev3eporeceptor AT behrrudiger thecytokinereceptorcrlf3isahumanneuroprotectiveev3eporeceptor AT heinrichralf thecytokinereceptorcrlf3isahumanneuroprotectiveev3eporeceptor AT knorrdebbray cytokinereceptorcrlf3isahumanneuroprotectiveev3eporeceptor AT rodriguezpoloignacio cytokinereceptorcrlf3isahumanneuroprotectiveev3eporeceptor AT pieshannas cytokinereceptorcrlf3isahumanneuroprotectiveev3eporeceptor AT schwedhelmdomeyernicola cytokinereceptorcrlf3isahumanneuroprotectiveev3eporeceptor AT paulsstephanie cytokinereceptorcrlf3isahumanneuroprotectiveev3eporeceptor AT behrrudiger cytokinereceptorcrlf3isahumanneuroprotectiveev3eporeceptor AT heinrichralf cytokinereceptorcrlf3isahumanneuroprotectiveev3eporeceptor |